Ruffer Portfolio holdings
Ruffer is an independent investment manager owned and run by its partners, with a single global strategy aimed at not losing money over any rolling 12-month period. Jonathan Ruffer, who began as a stockbroker and then became a barrister, started it in 1994 with Robert Shirley, 14th Earl Ferrers, and Jane Tufnell, and it became Ruffer LLP in 2004. The firm starts by weighing the risks it sees in markets and picking assets that should protect the portfolio if they come true, then takes on growth mainly through global stocks. It runs a stock-market-listed investment company, and its clients include pension plans, charities and family offices.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$206M |
| 2 |
Freeport-McMoran
FCX
|
+$112M |
| 3 |
Lockheed Martin
LMT
|
+$85M |
| 4 |
Annaly Capital Management
NLY
|
+$65.5M |
| 5 |
Barrick Mining
B
|
+$46.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$44.1M |
| 2 |
VIAB
Viacom Inc. Class B
VIAB
|
+$15.7M |
| 3 |
Johnson & Johnson
JNJ
|
+$7.12M |
| 4 |
Leidos
LDOS
|
+$3.46M |
| 5 |
Baidu
BIDU
|
+$3.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.58% |
| 2 | Industrials | 21.2% |
| 3 | Financials | 9.51% |
| 4 | Materials | 8.52% |
| 5 | Real Estate | 7.59% |
Similar funds
Ruffer's Q4 2013 Portfolio in Review
As of Q4 2013, Ruffer held 100 positions worth $2.82B, up 31% from $2.15B the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Ruffer deployed $516M of net new capital in Q4 2013, opening 12 new positions and adding to 20 existing holdings. Its largest new stake was Qualcomm: 2,918,160 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Merck, an estimated $44.1M trimmed.
- Ruffer's largest Q4 2013 buy was Qualcomm: 2,918,160 shares worth $216M.
- Ruffer added most to Lockheed Martin in Q4 2013, an estimated $85M increase.
- Ruffer's biggest Q4 2013 reduction was Merck, cutting an estimated $44.1M.
- Ruffer fully exited Teva Pharmaceutical Industries Limited in Q4 2013, selling an estimated $3.05M.
- Ruffer's ten largest holdings make up 77% of its $2.82B portfolio in Q4 2013.
- Ruffer opened 12 new positions and closed 8 in Q4 2013.
- Ruffer's portfolio value rose 31% quarter-over-quarter to $2.82B.
Based on Ruffer's 13F filing for Q4 2013, filed 13 Feb 2014.